Sun Pharma gets China NMPA approval for ILUMETRI to treat moderate-to-severe plaque psoriasis EP News Bureau May 31, 2023 In China clinical studies, the PASI 75 response rate reached a high level after 28 weeks of treatment with ILUMETRI and maintained…
